March 12 (Reuters) - Adolor Corp. (ADLR.O: Quote, Profile , Research) said on Monday that its partner Glaxo Group Ltd. has planned an additional Phase III study to evaluate the efficacy and safety of the experimental bowel treatment drug, Entereg.
March 12 (Reuters) - Adolor Corp. (ADLR.O: Quote, Profile , Research) said on Monday that its partner Glaxo Group Ltd. has planned an additional Phase III study to evaluate the efficacy and safety of the experimental bowel treatment drug, Entereg.
